Why Choose Duke
Leaders in HIV Research and Treatment
Duke researchers played integral roles in the development of several key drugs used to treat HIV, including AZT (zidovudine) and T20 (enfuvirtide). We provide compassionate, caring treatment to people with HIV. We use the latest therapies available, connect you with a physician who will take care of you every step of your journey, and provide ongoing social work support in a comforting, nonjudgmental environment.
Access to Clinical Trials
Our doctors are very active in research in all aspects of infectious diseases. As a result, you may be eligible to participate in clinical trials and gain access to new therapies before they become widely available.
Advanced Care for Respiratory Viruses Including Influenza
Our infectious disease and critical care specialists incorporate innovative approaches -- including novel uses of extracorporeal membrane oxygenation (ECMO) -- to care for patients who are very ill with influenza and its complications.
Nontuberculous Mycobacterial Infections (NTM) Expertise
We have nationally recognized expertise in treating these complicated infections and are listed in the NTM Info and Research Inc. (NTMir) directory of recommended providers.
Expertise in Preventing and Treating Infections Caused by Superbugs
Our doctors are skilled in existing and new strategies for fighting methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile (“C diff”), carbapenem-resistant Enterobacteriaceae (CRE), and other serious multi-drug-resistant organisms.